ArticleResearch and practice in thrombosis and haemostasis2018

Rationale and design of a phase III safety trial of idarucizumab in children receiving dabigatran etexilate for venous thromboembolism.

Manuela Albisetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.